International Myeloma Foundation
MYELOMA MINUTE | Up To The Minute News | 9.9.2021
African american family in living room on laptop
waldenstrom award winner vincent rajkumar
Congratulations to IMF Board Member Dr. S. Vincent Rajkumar on Receiving the Prestigious Waldenström Award for Outstanding Research
IMF Board Member Dr. S. Vincent Rajkumar, professor of medicine at the Mayo Clinic, was recognized Wednesday by the International Myeloma Society for his outstanding contribution to myeloma research. Dr. Rajkumar received the 2021 Waldenström Award, named for Prof. Jan Waldenström, a pioneer in treating blood cancers, during the society’s annual meeting this week in Vienna. Read the full press release now.
2020LearnMoreButton.png
imf twitch banner
Save the Date: #KNOWMYELOMA Variety Show on Twitch.TV on September 30
The #KNOWMYELOMA Variety Show will stream on Twitch.tv on Thursday, September 30, 2021 at 6 p.m. PT / 9 p.m. ET.  It features performers who have been touched in one way or another by myeloma, including internationally touring comedian Forrest Shaw, “Ologies” podcast host Alie Ward, Dance Theatre of Harlem ballerina Daphne Lee, LA-based writer and mom Jen Curran, IMF Chief Medical Officer Dr. Joseph Mikhael, and more!

The show closes out September’s Blood Cancer Awareness Month (BCAM). Throughout this month, the IMF asks one simple question: “Do You Know Myeloma?” and invites the public to explore the campaign at the link below.
2020LearnMoreButton.png
m power baltimore banner v2
Join the IMF’s Baltimore-Area Campaign to Raise Myeloma Awareness and Improve Outcomes in the African-American Community
To spread the word about the risk and impact of multiple myeloma in the African-American community, the IMF is presenting a free, virtual myeloma workshop on Saturday, September 25, at 10 a.m. ET. In time for September’s Blood Cancer Awareness Month, this workshop is part of the IMF’s initiative in Baltimore and surrounding areas to change the course of multiple myeloma by removing barriers to early diagnosis and treatment for African Americans (for whom myeloma is two times more prevalent than it is in all other races).
register button
clinical-trials-paper.jpg
Learn More About This Actively Accruing Venetoclax Clinical Trial
The NCT02899052 phase II, multi-center clinical trial uses venetoclax in patients with relapsed or refractory multiple myeloma who have received at least one prior line of therapy. This study will evaluate the safety and effectiveness of venetoclax in combination with carfilzomib and dexamethasone, compared with a standard treatment of carfilzomib and dexamethasone. This study will enroll 120 patients internationally.
2020LearnMoreButton.png
miracles-for-myeloma-jersey.jpg
Register Now for the Ninth Annual Miracles for Myeloma 5K Virtual Run/Walk
The Ninth Annual Miracles for Myeloma Virtual 5K Run/Walk will take place on Saturday, September 18, 2021. To participate, run, walk, or a use a treadmill to complete a 5K (3.1 miles) any time in the month of September. Record your best time and submit it before September 18. You can run as an individual or start a virtual team. Learn all the details at the link below!
register button
490x245NovisGrant.png
Calling All Researchers: Submit Your Grant Applications
The Brian D. Novis Research Grants honor IMF founder Brian Novis, who succumbed to multiple myeloma in July of 1992. The grants are awarded to researchers working in the field of multiple myeloma and related disorders, including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. The 2022 grants will support senior research projects with $80,000 each and junior research projects with $50,000 each. The deadline to submit the applications is October 1, 2021. 
2020ButtonApplyNow.png
ask doctor durie video image
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
This Week’s Question:

When a myeloma patient’s kidney creatinine levels increase, does this indicate a relapse?
Watch Now
 
Clinical Trial Fact Sheets

Smart Patients: Join the Conversation

CANOVA Trial (Accruing)

NCT02899052 Trial (Accruing)

NCT03314181 Trial (Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)
Upcoming Events & Replays
Donate Now
Hatfield Hike 2021

Watch the Replay
COVID-19 and Myeloma Webinar

Watch the Replay
Financial Resources Webinar

Watch the Replay
M-Power Charlotte Community Workshop

Click here to see all events
 

We Thank Our Sponsors:

Amgen, Bristol Myers Squibb, Karyopharm Therapeutics, Oncopeptides Inc.,
Sanofi-Genzyme, and Takeda Oncology
We also thank individuals like you for your continued support!
Subscribe Button@2x.jpg
2020ButtonDonateBurg.png
Join the conversation at The International Myeloma Foundation
Facebook Facebook: /Myeloma  |  Twitter Twitter @IMFMyeloma  |  Instagram Instagram @IMFmyeloma

www.myeloma.org
This email was sent by:
The International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
Connect with the IMF InfoLine
1-800-452-2873
We respect your privacy and your preferences for communications of this nature.
Home  •  Unsubscribe  •  Privacy Policy
View as web page